The program will address, among other topics, quality and safety criteria of plasma for fractionation and plasma-derived products, steps to avoid wasting recovered plasma and increase availability for plasma protein manufacture, single-use processing for local plasma protein purification and virus inactivation, regulatory considerations and cost considerations. The complete workshop program is available online.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch
as we evolve throughout 2022.
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively
to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.